Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 672825, 6 pages
http://dx.doi.org/10.1155/2014/672825
Research Article

Determinants of Default from Pulmonary Tuberculosis Treatment in Kuwait

1Tuberculosis Diagnosis and Treatment Center, Shanghai, Pulmonary Hospital, School of Medicine, Tongji University, 507 Zheng Min Road, Shanghai 200433, China
2Community, Environmental and Occupational Medicine Department, Minufiya University, Egypt
3Public Health Department, Tanta Faculty of Medicine, Egypt
4Ports and Borders Health Division, P.O. Box 35180, 36052 Shaab, Kuwait

Received 17 August 2013; Accepted 9 October 2013; Published 6 April 2014

Academic Editors: R. Diel and A. Khan

Copyright © 2014 Qing Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Stop TB partnership: TB any where is TB every where, stop TB fact sheet,” 2006, www.stoptb.org.
  2. Department of Public Health, Ministry Of Health (MOH), Kuwait, “TB annual report,” Tech. Rep., 2006. View at Google Scholar
  3. L. Clancy, H. L. Rieder, D. A. Enarson, and S. Spinaci, “Tuberculosis elimination in the countries of Europe and other industrialized countries,” European Respiratory Journal, vol. 4, no. 10, pp. 1288–1295, 1991. View at Google Scholar · View at Scopus
  4. World Health Organization, “WHO tuberculosis programme: framework for effective tuberculosis control,” Tech. Rep. WHO/TB/94.179, World Health Organization, Geneva, Switzerland, 1994. View at Google Scholar
  5. J. P. Zellweger and P. Coulon, “Outcome of patients treated for tuberculosis in Vaud County, Switzerland,” International Journal of Tuberculosis and Lung Disease, vol. 2, no. 5, pp. 372–377, 1998. View at Google Scholar · View at Scopus
  6. W. Wobeser, L. Yuan, M. Naus et al., “Outcome of pulmonary tuberculosis treatment in the tertiary care setting—Toronto 1992/93,” Canadian Medical Association Journal, vol. 160, no. 6, pp. 789–794, 1999. View at Google Scholar · View at Scopus
  7. D. P. Chin, K. C. Cummings, S. Sciortino et al., “Progress and problems in achieving the United States national target for completion of antituberculosis treatment,” International Journal of Tuberculosis and Lung Disease, vol. 4, no. 8, pp. 744–751, 2000. View at Google Scholar · View at Scopus
  8. R. Centis, A. Ianni, and G. B. Migliori, “Evaluation of tuberculosis treatment results in Italy, report 1998. Tuberculosis section of the National AIPO Study Group on Infectious Disease and the SMIRA Group,” Monaldi Archives for Chest Disease, vol. 55, no. 4, pp. 293–298, 2000. View at Google Scholar
  9. L. P. Ormerod, N. Horsfield, and R. M. Green, “Tuberculosis treatment outcome monitoring: blackburn 1988–2000,” International Journal of Tuberculosis and Lung Disease, vol. 6, no. 8, pp. 662–665, 2002. View at Google Scholar · View at Scopus
  10. J. A. Caylà, J. A. Caminero, R. Rey, N. Lara, X. Vallés, and H. Galdós-Tangüis, “Current status of treatment completion and fatality among tuberculosis patients in Spain,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 4, pp. 458–464, 2004. View at Google Scholar · View at Scopus
  11. EuroTB and the National Coordinators for Tuberculosis Surveillance in the WHO European Region, “Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2004,” Tech. Rep., Institut de Veille Sanitaire, Saint-Maurice, France, 2006. View at Google Scholar
  12. T. Lillebaek, S. Poulsen, and A. Kok-Jensen, “Tuberculosis treatment in Denmark: treatment outcome for all Danish patients in 1992,” International Journal of Tuberculosis and Lung Disease, vol. 3, no. 7, pp. 603–612, 1999. View at Google Scholar · View at Scopus
  13. L. Trnka, D. Daňková, and F. Krejbich, “Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country?” International Journal of Tuberculosis and Lung Disease, vol. 5, no. 3, pp. 250–256, 2001. View at Google Scholar · View at Scopus
  14. P. Helbling, C. Medinger, E. Altpeter, P.-A. Raeber, D. Beeli, and J.-P. Zellweger, “Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996,” Swiss Medical Weekly, vol. 132, no. 35-36, pp. 517–522, 2002. View at Google Scholar · View at Scopus
  15. L. P. Ormerod and R. J. Prescott, “The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998,” Clinical Medicine, vol. 3, no. 1, pp. 57–61, 2003. View at Google Scholar · View at Scopus
  16. A. Faustini, A. J. Hall, and C. A. Perucci, “Tuberculosis treatment outcomes in Europe: a systematic review,” European Respiratory Journal, vol. 26, no. 3, pp. 503–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. WHO, IUATLD, and KNCV, “Revised international definitions in tuberculosis control,” International Journal of Tuberculosis and Lung Disease, vol. 5, no. 3, pp. 213–215, 2001. View at Google Scholar
  18. J. F. Broekmans, G. B. Migliori, H. L. Rieder et al., “European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group,” European Respiratory Journal, vol. 19, no. 4, pp. 765–775, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Veen, M. Raviglione, H. L. Rieder et al., “Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients,” European Respiratory Journal, vol. 12, no. 2, pp. 505–510, 1998. View at Google Scholar · View at Scopus
  20. EuroTB, “Classification of treatment outcomes,” WHO Euro/EuroTB Joint Data Collection—CISID, 2001.
  21. M. G. Farah, A. Tverdal, T. W. Steen, E. Heldal, A. B. Brantsaeter, and G. Bjune, “Treatment outcome of new culture positive pulmonary tuberculosis in Norway,” BMC Public Health, vol. 5, article 14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Falzon, Y. Le Strat, F. Belghiti, and A. Infuso, “Exploring the determinants of treatment success for tuberculosis cases in Europe,” International Journal of Tuberculosis and Lung Disease, vol. 9, no. 11, pp. 1224–1229, 2005. View at Google Scholar · View at Scopus
  23. “Guide for treatment of tuberculosis for high prevalence countries. Paris: International Union Against Tuberculosis and Lung Disease,” 2000.
  24. M. C. Raviglione and I. M. Smith, “XDR tuberculosis—implications for global public health,” The New England Journal of Medicine, vol. 356, no. 7, pp. 656–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. Ministry Of Planning (MOP), Kuwait, Estimated Mid-Year Population Census, 2006.
  26. J. F. Broekmans, G. B. Migliori, H. L. Rieder et al., “European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group,” European Respiratory Journal, vol. 19, no. 4, pp. 765–775, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. “Tuberculosis control and research strategies for the 1990s: memorandum from a WHO meeting,” Bulletin of the World Health Organization, vol. 70, no. 1, pp. 17–21, 1992.
  28. D. A. Enarson, “Tuberculosis control in low-income countries,” in Tuberculosis: A Comprehensive International Approach, L. Reichman and E. Herschfield, Eds., Lung Biology, Marcel Dekker, 2nd edition, 1999. View at Google Scholar
  29. A. Rouillon, S. Perdrizet, and R. Parrot, “Transmission of tubercle bacilli: the effects of chemotherapy,” Tubercle, vol. 57, no. 4, pp. 275–299, 1976. View at Google Scholar · View at Scopus
  30. Centers for Disease Control and Prevention, “Emergence of Mycobacterium tuberculosis with extensive resistance to second line drugs worldwide, 2000–2004,” Morbidity and Mortality Weekly Report, vol. 55, no. 11, pp. 301–305, 2006. View at Google Scholar